Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-10-01 Alcohol dependence
These products should normally only be initiated by the community drug and alcohol team, or other specialist
Links
MHRA Drug Safety Update Jan 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury- NICE CG100: Alcohol-use disorders: diagnosis and management of physical complications
- NICE CG115: Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE TA325: Nalmefene for reducing alcohol consumption in people with alcohol dependence